Read the latest updates about the COVID-19 vaccine at Fox Chase →
Nga Nguyen, a technician in the department of nuclear medicine, uses molecular breast imaging as a screening tool to detect signs of breast cancer.
Fox Chase Cancer Center is now offering molecular breast imaging (MBI), a new diagnostic test for breast cancer. This technology improves early detection of breast cancer and, helps assess the extent of cancer in patients already diagnosed. MBI is not a recommended diagnostic tool for younger women of child-bearing age due to the low dose, full body exposure to radiation.
MBI is an alternative to magnetic resonance imaging (MRI), which may not be an option for those with claustrophobia, have metal in the body or have poor kidney function. As with MRI, MBI can be useful as a screening tool in detecting breast cancer that is difficult to detect using mammography alone. MBI provides clear images, even for those with dense breast tissue. For those with dense breast tissue, MBI’s technology can detect tumors that are not visible with mammography.
MBI is safe for patients with breast implants and is cost-effective.
The new technology was purchased through the generous support of the Friends of Fox Chase and a charitable donation by the Flyers Fight For Lives organization.